Abstract
Olfactory disturbances induced by the anticancer drug tegafur were studied in separate clinical and experimental investigations. Five patients with olfactory dysfunction after tegafur were studied and were found to have normal endoscopic findings of the olfactory cleft mucosa. The average period for drug administration was 22 months. Recovery from the olfactory disturbance was poor and biopsy of the olfactory mucosa revealed severely degenerated epithelium. In experimental studies in a guinea pig animal model, effects of oral tegafur on mitotic cells in the olfactory epithelium were examined using bromodeoxyuridine (BrdU) uptake as index. At the conclusion of 3 weeks' treatment, no pronounced morphological changes were seen, but the number of BrdU-incorporating cells decreased in proportion to the dose of tegafur used. Following long-term administration of tegafur 18 months, mitotic cells reacting to BrdU or proliferating cell nuclear antigen had virtually disappeared, indicating persistent inhibition of mitotic cell activity. Morphological changes present included decreased olfactory cell numbers, loss of cells in areas just above basal cells and degeneration of the mucous layer.
Similar content being viewed by others
References
Aoki A, Suzaki H, Chow M (1989) Olfactory disturbance caused by tegafur; two cases. Pract Otol (Kyoto) 82:385–389
Gratzner H (1982) Monoclonal antibody to 5-bromo- and 5iododeoxyuridine. Science 218:474–475
Kohsuke S, Manabu T (1980) Preservation of cell cycle characteristics in solid tumor in vitro. Cancer Res 40:4810–4812
Nakamura H (1991) Immunohistochemical observations of dividing cells in olfactory epithelium using anti-BrdU antibody. Eur Arch Otorhinolaryngol 248:298–301
Nakamura H, Fujiwara M, Nakano Y (1993) The immunohistochemical observations of dividing cells in the olfactory epithelium. Am J Rhinol 7:205
Sternberger LA (1979) Immunocytochemistry, 2nd edn. Wiley, New York
Wassem NH, Lane DP (1990) Monoclonal antibody analysis of the proliferating cell nuclear antigen (PCNA). Structural conversation and the detection of a nuclear form. J Cell Sci 96:121–129
Zusho H, Asaka H, Okamoto M (1981) Diagnosis of olfactory disturbance. Antis Nasus Larynx (Tokyo) 8:27–34
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nakamura, H., Nonomura, N., Fujiwara, M. et al. Olfactory disturbances caused by the anti-cancer drug tegafur. Eur Arch Otorhinolaryngol 252, 48–52 (1995). https://doi.org/10.1007/BF00171440
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00171440